摘要 |
<p>The present invention is directed to the compound of formula (II), or a solvate thereof, or crystalline forms thereof; to a pharmaceutical composition comprising a pharmaceutically effective amount of the compound of formula (II), including crystalline forms thereof, and a pharmaceutically acceptable carrier; and to the use of a compound of formula (II), or crystalline forms thereof, for treating a patient suffering from, or subject to, a pathological condition capable of being ameliorated by inhibiting IKK-2, and methods related thereto.</p> |
申请人 |
MILLENNIUM PHARMACEUTICALS, INC.;HICKS, FREDERICK, A.;COOPER, MARTIN, IAN;LANGSTON, MARIANNE;ST. CLAIR BROWN, ADRIAN |
发明人 |
HICKS, FREDERICK, A.;COOPER, MARTIN, IAN;LANGSTON, MARIANNE;ST. CLAIR BROWN, ADRIAN |